Growth hormone receptor signaling is dispensable for HSC function and aging

Blood

Volumn 124, Issue 20, 2014, Pages 3076-3080

  Stewart, Morag H ^a,b   Gutierrez Martinez, Paula ^a,b   Beerman, Isabel ^a,b   Garrison, Brian ^a,b   Gallagher, Emily J ^c   LeRoith, Derek ^c   Rossi, Derrick J ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; GROWTH HORMONE RECEPTOR; RECOMBINANT GROWTH HORMONE; GROWTH HORMONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CELL AGING; CONTROLLED STUDY; EX VIVO STUDY; GENE DELETION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC SYSTEM; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; AGING; ANIMAL; CYTOLOGY; GENE EXPRESSION; GENETICS; METABOLISM;

AGING; ANIMALS; CELL AGING; GENE DELETION; GENE EXPRESSION; GROWTH HORMONE; HEMATOPOIESIS; HEMATOPOIETIC STEM CELLS; MICE; RECEPTORS, SOMATOTROPIN; SIGNAL TRANSDUCTION;

EID: 84911891046     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-05-575308     Document Type: Article

References (26)

1. Beerman I, Maloney WJ, Weissmann IL, Rossi DJ. Stem cells and the aging hematopoietic system. Curr Opin Immunol. 2010;22(4):500-506.
2. Geiger H, de Haan G, Florian MC. The ageing haematopoietic stem cell compartment. Nat Rev Immunol. 2013;13(5):376-389.
3. Ding J, Sackmann-Sala L, Kopchick JJ. Mouse models of growth hormone action and aging: a proteomic perspective. Proteomics. 2013; 13(3-4):674-685.
4. Taub DD, Murphy WJ, Longo DL. Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways. Curr Opin Pharmacol. 2010;10(4):408-424.
5. French RA, Broussard SR, Meier WA, et al. Age-associated loss of bone marrow hematopoietic cells is reversed by GH and accompanies thymic reconstitution. Endocrinology. 2002;143(2):690-699.
6. Carlo-Stella C, Di Nicola M, Milani R, et al. Age-and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone. Exp Hematol. 2004;32(2):171-178.
7. Chen BJ, Deoliveira D, Spasojevic I, et al. Growth hormone mitigates against lethal irradiation and enhances hematologic and immune recovery in mice and nonhuman primates. PLoS ONE. 2010; 5(6):e11056.
8. Pello OM, Moreno-Ortiz MC, Rodríguez-Frade JM, et al. SOCS up-regulation mobilizes autologous stem cells through CXCR4 blockade. Blood. 2006;108(12):3928-3937.
9. Carlo-Stella C, Di Nicola M, Milani R, et al. Use of recombinant human growth hormone (rhGH) plus recombinant human granulocyte colony-stimulating factor (rhG-CSF) for the mobilization and collection of CD341 cells in poor mobilizers. Blood. 2004;103(9):3287-3295.
10. van der Klaauw AA, Pereira AM, Rabelink TJ, et al. Recombinant human GH replacement increases CD341 cells and improves endothelial function in adults with GH deficiency. Eur J Endocrinol. 2008;159(2):105-111.
11. Hanley MB, Napolitano LA, McCune JM. Growth hormone-induced stimulation of multilineage human hematopoiesis. Stem Cells. 2005;23(8): 1170-1179.
12. Seita J, Sahoo D, Rossi DJ, et al. Gene Expression Commons: an open platform for absolute gene expression profiling. PLoS ONE. 2012;7(7):e40321.
13. Gazit R, Garrison BS, Rao TN, et al; Immunological Genome Project Consortium. Transcriptome analysis identifies regulators of hematopoietic stem and progenitor cells. Stem Cell Reports. 2013;1(3):266-280.
14. Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, Goodell MA. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol. 2007;5(8): e201.
15. Xu X, Bennett SA, Ingram RL, Sonntag WE. Decreases in growth hormone receptor signal transduction contribute to the decline in insulinlike growth factor I gene expression with age. Endocrinology. 1995;136(10):4551-4557.
16. Lieberman SA, Mitchell AM, Marcus R, Hintz RL, Hoffman AR. The insulin-like growth factor I generation test: resistance to growth hormone with aging and estrogen replacement therapy. Horm Metab Res. 1994;26(5):229-233.
17. Velasco B, Cacicedo L, Melian E, Fernández-Vázquez G, Sánchez-Franco F. Sensitivity to exogenous GH and reversibility of the reduced IGF-I gene expression in aging rats. Eur J Endocrinol. 2001;145(1):73-85.
18. Rotwein P. Mapping the growth hormone-Stat5b-IGF-I transcriptional circuit. Trends Endocrinol Metab. 2012;23(4):186-193.
19. Vesterlund M, Zadjali F, Persson T, et al. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels. PLoS ONE. 2011;6(9): e25358.
20. Beerman I, Seita J, Inlay MA, Weissman IL, Rossi DJ. Quiescent hematopoietic stem cells accumulate DNA damage during aging that is repaired upon entry into cell cycle. Cell Stem Cell. 2014;15(1):37-50.
21. Rossi DJ, Bryder D, Zahn JM, et al. Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci USA. 2005;102(26): 9194-9199.
22. Wu Y, Liu C, Sun H, et al. Growth hormone receptor regulates b cell hyperplasia and glucose-stimulated insulin secretion in obese mice. J Clin Invest. 2011;121(6):2422-2426.
23. Harrison DE, Lerner CP. Most primitive hematopoietic stem cells are stimulated to cycle rapidly after treatment with 5-fluorouracil. Blood. 1991;78(5):1237-1240.
24. Wilson A, Laurenti E, Oser G, et al. Hematopoietic stem cells reversibly switch from dormancy to self-renewal during homeostasis and repair. Cell. 2008;135(6):1118-1129.
25. Randall TD, Weissman IL. Phenotypic and functional changes induced at the clonal level in hematopoietic stem cells after 5-fluorouracil treatment. Blood. 1997;89(10):3596-3606.
26. Beerman I, Bock C, Garrison BS, et al. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell. 2013;12(4): 413-425.